Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
Background Most targeted anticancer therapies, as well as cytotoxic and radiation therapies, are encumbered by the development of secondary resistance by cancer cells. Resistance is a complex phenomenon involving multiple mechanisms, including activation of signaling pathways such as phosphatidylino...
Saved in:
| Published in: | Cancer chemotherapy and pharmacology Vol. 71; no. 4; pp. 829 - 842 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
Berlin/Heidelberg
Springer-Verlag
01.04.2013
Springer Springer Nature B.V |
| Subjects: | |
| ISSN: | 0344-5704, 1432-0843, 1432-0843 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!